Macy's Inc (M) Stock News

Grail's stock surged 80% following a positive FDA panel vote on its Galleri multi-cancer early detection test. However, the article warns investors that while FDA approval and insurer adoption are important, the critical risk factor is the price insurers will be willing to pay for the $949 test, which depends on cost-benefit analyses and clinical data.

Individual investors hold approximately two-thirds of all Bitcoin (14 million BTC), while corporations, ETFs, and governments collectively own only about 13% of the supply. As institutional buyers and governments increasingly seek Bitcoin, they will need to purchase from current individual holders at higher prices, potentially creating a buying opportunity for those willing to hold long-term as supply becomes increasingly constrained.

To generate $1,000 monthly in dividend income ($12,000 annually), investors should diversify across five pharmaceutical stocks rather than concentrating in high-yield Pfizer alone. Investing $70,000 each in Pfizer, Johnson & Johnson, AbbVie, Bristol Myers Squibb, and Amgen creates a balanced portfolio that reduces risk from patent expirations and potential dividend cuts while maintaining steady income.

Cerebras Systems expects $880-890 million in core revenue for 2026, comparable to Nvidia's data center business revenue of $830 million in fiscal 2017. However, the similarities end there. Unlike Nvidia, which had a profitable gaming business funding its AI expansion, Cerebras is unprofitable with negative operating margins and relies on just three customers for three-quarters of revenue. The stock trades at 44x expected revenue and is valued at two-thirds of Nvidia's entire 2016 market cap, raising questions about whether it can replicate Nvidia's growth trajectory.

The article compares Arm Holdings and Marvell Technology as AI infrastructure plays. Arm dominates smartphone processor architecture with 93.88% gross margins but faces competition from custom silicon development. Marvell leads data center connectivity with 32.6% net margins and aggressive growth targets ($20B by FY2028, $70-90B by FY2031), though it carries customer concentration risk. The author recommends Marvell as the better buy due to superior valuation metrics and stronger AI demand tailwinds.

Moderna stock has surged over 500% this year, driven by investor enthusiasm about its personalized cancer vaccine candidate. The stock now trades 61% above Wall Street's average price target. While the stock may face near-term pullback after its rapid gains, the company's strong pipeline and long-term growth potential in mRNA-based therapies suggest it remains a solid long-term biotech investment, though scaling personalized vaccines presents manufacturing challenges.

Roche announced one-year Phase III data from MEERKAT and SANDCAT studies showing vamikibart, an anti-IL-6 monoclonal antibody, demonstrated sustained vision improvements and macular thickness reductions in uveitic macular edema patients. The FDA has accepted Roche's Biologics License Application with an approval decision expected by July 2027. If approved, vamikibart would be the first non-steroid targeted treatment for UME, potentially establishing a new standard of care.

The Vanguard S&P 500 ETF (VOO) excludes major AI-related semiconductor companies like SpaceX, Taiwan Semiconductor, Samsung Electronics, SK Hynix, and ASML due to S&P 500 inclusion rules requiring 12 months of public trading. The Vanguard Total World Stock ETF (VT) offers broader global diversification with exposure to these international semiconductor leaders at a comparable 0.06% expense ratio, making it potentially more attractive for investors seeking AI chip exposure.

MercadoLibre emerges as the superior investment choice compared to Coupang, driven by significantly higher revenue growth (39.1% vs 14.1%), superior profitability (6.9% net margin vs 0.6%), and a much larger customer base across 18 countries. While Coupang trades at a lower valuation multiple, MercadoLibre's robust cash flow generation and expanding fintech ecosystem provide better long-term value despite operating in volatile emerging markets.

Abbott Laboratories is positioned for significant growth potential, with analyst projections suggesting the stock could reach approximately $210 per share by 2036 based on conservative 8% annual earnings growth. The healthcare company's strong track record includes a 9.7% compound annual earnings-per-share growth rate over the past decade, bolstered by strategic acquisitions. Abbott's status as a Dividend King with 54 consecutive years of dividend increases, combined with a 2.5% dividend yield, makes it an attractive option for income-focused investors seeking defensive holdings with upside potential.

NEAR Protocol has surged 233% in 2026, driven by AI narratives, but the article cautions against viewing it as a path to wealth. Despite ranking as the top AI cryptocurrency by market cap and launching a spot ETF, NEAR's volatile history and lack of long-term consistency raise concerns. The author remains skeptical, noting that AI crypto narratives shift rapidly and other AI tokens like Venice Token have outperformed NEAR this year.

AST SpaceMobile, a LEO satellite developer with a $15.3 billion market cap, currently generates no commercial revenue despite holding $3.7 billion in liquidity. The company relies on government contracts and prepayments from telecom partners. However, analysts project significant growth potential as AST plans to expand its satellite constellation to 45 satellites next year, with revenue expected to surge from $169 million in 2026 to $1.73 billion by 2028.

ExxonMobil CEO Darren Woods initially called Venezuela 'uninvestable,' but the company is now reportedly in talks to invest in Venezuelan oilfields. However, Venezuela's production capacity remains severely constrained at 1.2 million barrels per day versus its historical peak of 3.5 million, meaning any investment there won't materially impact global oil prices in the near term. For ExxonMobil investors, Venezuela represents a potential bonus rather than a core growth driver, with the company's primary growth engines being its operations in Guyana and the Permian Basin.

D-Wave Quantum Inc. (NASDAQ: QBTS) is under investigation for potential federal securities law violations following disappointing Q2 2026 financial results with revenue of $3.08 million, missing analyst expectations of $4.03-$4.08 million. The company's stock fell over 9% on August 6, 2026, and again on August 26, 2026, following the announcement of its CFO's resignation. Kessler Topaz Meltzer & Check, LLP is encouraging affected investors to contact the firm regarding potential legal claims.

The rise of AI agents is expected to drive explosive growth in the data center CPU market, projected to grow from $61.4 billion in 2025 to $210.6 billion by 2030. As AI agents require more CPUs relative to GPUs, semiconductor companies positioned in server CPU manufacturing and IP licensing stand to benefit significantly from this shift.

A securities fraud class action lawsuit has been filed against Duolingo, Inc. for investors who purchased stock between May 2, 2025 and February 26, 2026. The lawsuit alleges material misstatements regarding monetization strategies and user friction that negatively impacted daily active user (DAU) growth. Duolingo's stock declined significantly following disappointing Q3 results (DAU growth fell to 36% from 49%), a CFO resignation, and weak Q4 guidance showing only 20% DAU growth for 2026.

A class action lawsuit has been filed against The Simply Good Foods Company for allegedly making false statements regarding its OWYN acquisition. The lawsuit claims the company lost key personnel post-acquisition, faced product quality issues with a new pea protein supplier, engaged in excessive discounting to boost sales, and ultimately failed to achieve strategic goals, resulting in significant operational and financial problems for the OWYN segment.

Rosen Law Firm is urging UWM Holdings Corporation investors who purchased securities between March 9, 2026 and August 5, 2026 and suffered losses exceeding $100,000 to join a securities class action lawsuit before the October 13, 2026 lead plaintiff deadline. The lawsuit alleges that UWM Holdings made materially false statements regarding its hedging strategy for mortgage servicing rights, claiming the company deviated from its traditional non-hedging approach and over-hedged in anticipation of the Two Harbors transaction, creating excess hedging risk.

Major Saudi conferences to proceed, organisers say, despite deadly airport attack  Reuters

Vannor launched its agentic marketing platform featuring autonomous AI agents that manage end-to-end marketing workflows on proprietary NVIDIA infrastructure. The company reported a 30-fold increase in first-page Google rankings and a 554% increase in weekly search impressions within one month of deployment. The system operates across search content, paid advertising, landing pages, and social media while maintaining brand consistency and data privacy.

Warren Buffett's Berkshire Hathaway held Wells Fargo stock for nearly 30 years starting in 1989, but exited the position in 2022 following the bank's 2016 phony accounts scandal. While CEO Charlie Scharf successfully turned the bank around with operational improvements and regulatory compliance, Buffett had already sold due to frustration with the board and uncertainty about the turnaround timeline. The case illustrates the importance of reputation in banking and the challenge of identifying viable long-term turnaround opportunities.

Warren Buffett warned that excessive 'gambling' in the stock market and high valuations similar to pre-dot-com crash levels could lead to a market pullback. Despite the S&P 500's 78% gain over three years driven by AI enthusiasm, Buffett advises investors to focus on quality stocks at reasonable valuations rather than chasing quick gains.

Alphabet's Google Cloud revenue surged 82% to $24.8 billion in Q2, significantly outpacing search revenue growth of 17%. With 950 million Gemini app users and a $514 billion revenue backlog, Google Cloud is emerging as a primary growth driver for Alphabet's AI-focused future, though search still accounts for over half of total revenue.

The article argues that savings accounts with low interest rates cannot build meaningful wealth and recommends investing in the stock market for long-term retirement planning. It advocates for index funds like SPY and VOO as low-risk options, while also highlighting Alphabet as a solid individual stock pick due to its dominant position in search and advertising despite AI industry uncertainties.

Sigenergy showcased its latest intelligent energy solutions at IGEM Malaysia, delivering a keynote on AI-driven innovation in smart energy systems. The company signed MOUs with strategic partners Milieu and YT Energy to accelerate adoption of advanced energy solutions in Malaysia, while displaying its residential, C&I, and utility products including SigenStor Neo, SigenStack, and the Sigen PV 500H1 inverter.

Federal Reserve Chairman Kevin Warsh's statement that 'the Fed's predominant focus right now should be on prices' signals the central bank's priority on combating inflation over employment concerns. With inflation running above the 2% target, this messaging suggests interest rate increases are likely ahead. The lack of explicit Fed guidance has caused bond yields to rise and pressured high-yield dividend stocks in REITs, utilities, and consumer staples sectors, though this may present buying opportunities for long-term investors.

Rosen Law Firm is urging investors who purchased Beta Bionics common stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, which the FDA found was malfunctioning and dosing patients with dangerously high insulin levels. The firm claims thousands of complaints were filed with the FDA, contradicting defendants' assertions that issues were benign. The lead plaintiff deadline is November 3, 2026.

ConocoPhillips is reviewing an unsolicited $7 billion offer to purchase its Norway business and Teesside, U.K. assets. While the deal represents a significant transaction, it constitutes only a small portion of the company's $160+ billion market cap. The article suggests this development alone doesn't make ConocoPhillips more compelling than other energy stocks, and that oil price volatility driven by Middle East geopolitical tensions remains the more important factor for investors to monitor.

Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 9, 2026 merger. The lawsuit alleges that merger offering materials misrepresented regulatory compliance efforts and omitted material information about defendants' undisclosed hiring of Trump-connected lobbyists and lawyers to obtain backdoor access to DOJ officials to circumvent standard merger review processes. The complaint claims these practices contradicted attestations of 'reasonable best efforts' for regulatory approval and allowed the merger to close despite anticompetitive effects. The deadline to serve as lead plaintiff is December 8, 2026.

A securities class action lawsuit has been filed against Millrose Properties, Inc. for allegedly failing to disclose that it purchased $200 million in finished homes from parent company Lennar and leased them at a loss, contrary to stated business objectives. The disclosure by Hunterbrook Media on October 2, 2026 caused Millrose's stock to fall 8.5%, dropping from $24.61 to $22.51.